For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

Through the first three quarters of 2025, M&A activity overtook the entire 2024 total, according to Endpoints News. Editor and founder John Carroll wrote in October this might be the best time in 15 ...

Then, life science companies were scrambling for space — industrial vacancy rates dipped to as low as 2%. Deep‑pocketed developers from Silicon Valley and Boston came and spent millions speculating on ...

Wave's bullish start to the week was driven by the encouraging readout of a Phase 1 clinical study of WVE-007, its obesity ...

Agentforce Life Sciences platform continues to gain momentum across the healthcare industry. Recently, Novartis ($NVS) ...

The developer behind Philadelphia's largest life sciences building says the market needs patience after venture capital ...

Humans have it. So does Drosophila. But not yeast. That "it" is a small pause at the start of gene activity—a brief molecular halt that may have helped life evolve from simple cells to complex animals ...

Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative ...

Actively moving up the value chain toward drug discovery, development and digital therapeutics is key to sustaining the State ...

Wave Life Sciences Ltd is a pioneering force in genetic medicine, focusing on creating innovative treatments for serious ...

The Board on Life Sciences (BLS) was established in 1984 to serve as the focal point for addressing critical, emerging policy and technical issues associated with the life sciences and biotechnology ...

The 2024-25 Sustainability Report reflects the company’s long-term view-one that places science, responsibility, and ...